Sana Biotechnology, Inc. (NASDAQ:SANA) Given Consensus Recommendation of "Moderate Buy" by Analysts
Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the nine analysts that are covering the firm, Marketbeat reports. One equities...